The trajectory of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the loss of exclusivity in key territories has introduced considerable risk . Investors are now facing the effect of lower-cost alternati